Literature DB >> 6768086

Stimulus properties of antidepressants in the rat.

C N Jones, J L Howard, S T McBennett.   

Abstract

Various doses of bupropion HCl (Wellbatrin) (5, 10, and 20 mg/kg), a new phenylaminoketone antidepressant, were employed as cues in a two-lever operant discrimination from saline control injections in rats on an FR10 schedule of food reinforcement. Subjects reached and maintained a high level of discrimination in the O vs 20 mg/kg bupropion stimulus condition but not at the lower doses. In generalization testing, the following compounds produced dose-related responding on the bupropion lever: viloxazine, nomifensine, caffeine, d-amphetamine, cocaine, methylphenidate, and benzylpiperazine. Drugs that failed to show dose-related generalization included phenethylamine, thyrotropin-releasing hormone, imipramine, nortriptyline, amitriptyline, desipramine, mianserin, chlordiazepoxide, diazepam, scopolamine, phenobarbital, and morphine. With the important exception of viloxazine, the generalization profile of bupropion seems to reflect its previously reported locomotor stimulant effects in the rat rather than its antidepressant activity and suggests that species differences exist between man and rat with regard to the pharmacologic activity of this new antidepressant.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6768086     DOI: 10.1007/bf00431964

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  15 in total

1.  PSYCHOPHARMACOLOGY OF IMIPRAMINE AND DESIPRAMINE: A COMPARATIVE STUDY OF THEIR EFFECTS IN NORMAL MALES.

Authors:  A DIMASCIO; G HENINGER; G L KLERMAN
Journal:  Psychopharmacologia       Date:  1964-04-03

2.  COMPARISON BETWEEN IMIPRAMINE AND DESIPRAMINE IN NORMAL SUBJECTS AND THEIR ACTION IN DEPRESSIVE PATIENTS.

Authors:  W POELDINGER
Journal:  Psychopharmacologia       Date:  1963-05-21

3.  Behavioural despair in rats: a new model sensitive to antidepressant treatments.

Authors:  R D Porsolt; G Anton; N Blavet; M Jalfre
Journal:  Eur J Pharmacol       Date:  1978-02-15       Impact factor: 4.432

4.  Bupropion hydrochloride ((+/-) alpha-t-butylamino-3-chloropropiophenone HCl): a novel antidepressant agent.

Authors:  F E Soroko; N B Mehta; R A Maxwell; R M Ferris; D H Schroeder
Journal:  J Pharm Pharmacol       Date:  1977-12       Impact factor: 3.765

5.  Effects of imipramine on individuals varying in level of depression.

Authors:  A Dimascio; R E Meyer; L Stifler
Journal:  Am J Psychiatry       Date:  1968-02       Impact factor: 18.112

6.  Investigations on the action and mechanism of action of diphenylhydantoin as an antagonist of tetrabenazine and reserpine.

Authors:  V J Lotti; L Torchiana; C C Porter
Journal:  Arch Int Pharmacodyn Ther       Date:  1973-05

Review 7.  Pharmacology of tricyclic antidepressants.

Authors:  G V Rossi
Journal:  Am J Pharm Sci Support Public Health       Date:  1976 Mar-Apr

8.  Discriminative stimulus properties of desipramine.

Authors:  G Shearman; S Miksic; H Lal
Journal:  Neuropharmacology       Date:  1978-12       Impact factor: 5.250

9.  A comparison of bupropion hydrochloride with dexamphetamine and amitriptyline in healthy subjects.

Authors:  A W Peck; C E Bye; M Clubley; T Henson; C Riddington
Journal:  Br J Clin Pharmacol       Date:  1979-05       Impact factor: 4.335

10.  The discriminability of apsirin in arthritic and nonarthritic rats.

Authors:  A Weissman
Journal:  Pharmacol Biochem Behav       Date:  1976-11       Impact factor: 3.533

View more
  16 in total

Review 1.  Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.

Authors:  Linda P Dwoskin; Anthony S Rauhut; Kelley A King-Pospisil; Michael T Bardo
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

2.  Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents.

Authors:  Neil E Paterson; Allison Fedolak; Berend Olivier; Taleen Hanania; Afshin Ghavami; Barbara Caldarone
Journal:  Pharmacol Biochem Behav       Date:  2010-03-25       Impact factor: 3.533

3.  Nicotinic acetylcholine receptor efficacy and pharmacological properties of 3-(substituted phenyl)-2β-substituted tropanes.

Authors:  F Ivy Carroll; Bruce E Blough; S Wayne Mascarella; Hernán A Navarro; J Brek Eaton; Ronald J Lukas; M Imad Damaj
Journal:  J Med Chem       Date:  2010-11-08       Impact factor: 7.446

4.  Acute effects of the designer drugs benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) using functional magnetic resonance imaging (fMRI) and the Stroop task--a pilot study.

Authors:  Louise E Curley; Rob R Kydd; Michelle C Robertson; Avinesh Pillai; Nicolas McNair; HeeSeung Lee; Ian J Kirk; Bruce R Russell
Journal:  Psychopharmacology (Berl)       Date:  2015-04-19       Impact factor: 4.530

Review 5.  Role of training dose in drug discrimination: a review.

Authors:  Ian P Stolerman; Emma Childs; Matthew M Ford; Kathleen A Grant
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

6.  A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: evidence that dopamine is not a pharmacological target for sibutramine.

Authors:  D J Heal; A T Frankland; J Gosden; L J Hutchins; M R Prow; G P Luscombe; W R Buckett
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  Self-administration in baboons and the discriminative stimulus effects in rats of bupropion, nomifensine, diclofensine and imipramine.

Authors:  R J Lamb; R R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

8.  Pavlovian drug discrimination with bupropion as a feature positive occasion setter: substitution by methamphetamine and nicotine, but not cocaine.

Authors:  Jamie L Wilkinson; Chia Li; Rick A Bevins
Journal:  Addict Biol       Date:  2008-12-12       Impact factor: 4.280

9.  Characterization of the bupropion cue in the rat: lack of evidence for a dopaminergic mechanism.

Authors:  R D Blitzer; R E Becker
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

10.  A comparison of bupropion, dextroamphetamine, and placebo in mixed-substance abusers.

Authors:  L Miller; J Griffith
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.